Werewolf Therapeutics, Inc.
8-K
March 27, 2026
Key Highlights
- Exploring strategic alternatives including potential sale, merger, or partnershi...
- Proprietary INDUKINEâ„¢ platform remains the primary value driver
- Active cost-cutting measures to extend cash runway into Q4 2026
Read Analysis
🤖 AI Generated